Latest Attention-deficit hyperactivity disorder Stories
The European Biostimulants Market report defines and segments the biostimulants market in Europe with analysis and forecast of revenue.
STAR (Sensory Therapies And Research) Center, the premier treatment center for children with sensory challenges launches two new programs for children who would benefit from therapeutic activities
LEXINGTON, Massachusetts, July 17, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced top-line results from two Phase 4 efficacy and safety studies
Cumberland Academy of Georgia was recently included in an article assembling the 50 best private schools for students with special needs across the United States.
The inability to ignore irrelevant stimuli underlies the impaired working memory and cognition often experienced by individuals diagnosed with schizophrenia.
South Burlington’s Dr.
Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events.
Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use BOSTON, July 9, 2014 /PRNewswire-USNewswire/ -- Over the last 60 years, the U.S.
LOS ANGELES, July 9, 2014 /PRNewswire/ -- NeuroSigma, Inc.
Working memory in children is linked strongly to reading and academic achievement.
- Large; stout; burly.